Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
T cells Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/18/2023 24 0
BNT162b2 Approved by FDA Experimental Vaccine Jun/22/2022 65 0
mRNA-1273 Emergency use authorization Experimental Vaccine Jun/22/2022 27 1
Baricitinib Emergency use authorization Used to treat other disease Other treatment Feb/03/2022 33 2
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/03/2021 41 4
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
IVIg Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021 11 2
(E)-4-(4-((5-(4,5-Dimethyl-2-nitrophenyl)furan-2-yl)Methylene)-3-Methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid Potential treatment - theoretical effect Experimental Other treatment Apr/12/2021 1 0
Naproxol Potential treatment - theoretical effect Experimental Other treatment Apr/12/2021 1 0
Amsacrine Potential treatment - theoretical effect Used to treat other disease Other treatment Apr/12/2021 1 0
Excel (.xslx) CSV (.csv)